Attached files
| file | filename |
|---|---|
| EX-3.1 - First Surgical Partners Inc. | v212063_ex3-1.htm |
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): February 18, 2011
FIRST
SURGICAL PARTNERS INC.
(Exact
name of registrant as specified in its charter)
Arkson
Nutraceuticals Corp.
(Former
Name of Registrant)
|
Delaware
|
000-52458
|
51-0383940
|
|
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification Number)
|
411
First Street
Bellaire,
Texas 77401
(Address
of principal executive offices) (zip code)
713-665-1111
(Registrant's
telephone number, including area code)
Stephen
M. Fleming, Esq.
Law
Offices of Stephen M. Fleming PLLC
49 Front
Street, Suite 206
Rockville
Centre, New York 11570
Phone:
(516) 833-5034
Fax:
(516) 977-1209
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year
Effective
February 18, 2011, Arkson Nutraceuticals Corp. (the “Company”) changed its name
to “First Surgical Partners Inc.” In addition, effective February 22,
2011, the Company’s quotation symbol on the Over-the-Counter Bulletin Board was
changed from AKSN to FSPI. The new CUSIP number is
337139109.
As
previously disclosed in the Form 8-K Current Report filed with the Securities
and Exchange Commission on January 6, 2011, the Board of Directors of the
Company approved a change in the Company's fiscal year of September 30 to
December 31.
(d) Exhibits
|
Exhibit
No.
|
Description
|
|
3.1
|
Certificate
of Ownership by and between Arkson Nutraceuticals Corp. and First Surgical
Partners Inc.
|
SIGNATURES
Pursuant
to the requirements of the Securities and Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
FIRST
SURGICAL PARTNERS INC.
|
|||
|
Dated:
February 18, 2011
|
By:
|
/s/ Anthony
F. Rotondo
|
|
|
Name:
Anthony F. Rotondo
|
|||
|
Title:
Chief Executive Officer and President
|
|||